We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.

Inflammatory bowel disease (IBD) is a high-risk condition for human colorectal cancer. However, our mechanistic understanding of the link between inflammation and tumorigenesis in the colon is limited. Here we established a novel mouse model of colitis-associated cancer by genetically inactivating signal transducer and activator of transcription 3 (Stat3) in macrophages, with partial deletion in other myeloid and lymphoid cells. Inflammation developed in the colon of mutant mice spontaneously, and tumor lesions, including invasive carcinoma, arose in the inflamed region of the intestine with a frequency similar to that observed in human IBD patients. The development of both inflammation and tumors in the mutant mice required the presence of microflora. Indeed, inflammation was associated with disruption of colonic homeostasis, fulminant epithelial/tumor cell proliferation, and activation of the mammalian target of rapamycin (mTOR)-Stat3 pathway in epithelial and tumor cells. The activation of this pathway was essential for both the excess proliferation of epithelial/tumor cells and the disruption of colonic homeostasis in the mutant mice. Notably, a similar abnormal up-regulation of mTOR-Stat3 signaling was consistently observed in the colonic epithelial cells of human IBD patients with active disease. These studies demonstrate a novel mouse model of IBD-colorectal cancer progression in which disrupted immune regulation, mTOR-Stat3 signaling, and epithelial hyperproliferation are integrated and simultaneously linked to the development of malignancy.

Pubmed ID: 20042677 RIS Download

Mesh terms: Animals | Carcinoma | Cell Proliferation | Cell Transformation, Neoplastic | Colitis | Colon | Colorectal Neoplasms | Disease Models, Animal | Disease Progression | Humans | Inflammation | Inflammatory Bowel Diseases | Intestinal Mucosa | Intracellular Signaling Peptides and Proteins | Mice | Mice, Inbred C57BL | Mice, Transgenic | Protein-Serine-Threonine Kinases | STAT3 Transcription Factor | Signal Transduction | TOR Serine-Threonine Kinases

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: P01 CA100324
  • Agency: NCI NIH HHS, Id: U54-CA100926
  • Agency: NCI NIH HHS, Id: P30 CA013330
  • Agency: NCI NIH HHS, Id: P30-CA13330
  • Agency: PHS HHS, Id: R01-94173
  • Agency: NCI NIH HHS, Id: P01-CA100324
  • Agency: NCI NIH HHS, Id: U54 CA100926

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.